BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 32146108)

  • 1. Development of the predicted and standardized carbapenem usage metric: Analysis of the Japanese Diagnosis Procedure Combination payment system data.
    Maeda M; Muraki Y; Anno Y; Sawa A; Kusama Y; Ishikane M; Ohmagari N; Ohge H
    J Infect Chemother; 2020 Jun; 26(6):633-635. PubMed ID: 32146108
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Standardized Antimicrobial Administration Ratio: A New Metric for Measuring and Comparing Antibiotic Use.
    van Santen KL; Edwards JR; Webb AK; Pollack LA; O'Leary E; Neuhauser MM; Srinivasan A; Pollock DA
    Clin Infect Dis; 2018 Jul; 67(2):179-185. PubMed ID: 29409000
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A new carbapenem drug dosage metric for carbapenem usage and correlation with carbapenem resistance of Pseudomonas aeruginosa.
    Hirayama S; Yasui K; Murakami H; Kosugi T; Sakamoto M; Hanai Y; Matsuo K; Miyazaki T; Ishii Y; Nishizawa K; Tateda K
    J Infect Chemother; 2018 Dec; 24(12):949-953. PubMed ID: 30268412
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Higher third-generation cephalosporin prescription proportion is associated with lower probability of reducing carbapenem use: a nationwide retrospective study.
    Muller A; Bertrand X; Rogues AM; Péfau M; Alfandari S; Gauzit R; Dumartin C; Gbaguidi-Haore H;
    Antimicrob Resist Infect Control; 2018; 7():11. PubMed ID: 29387345
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Variation in a novel antipseudomonal antimicrobial consumption metric across hospital inpatient units at a Veterans Affairs hospital: A retrospective cohort study.
    Vissichelli NC; Bailey P; Sabo RT; Tassone D; Vaughan L; Stevens MP; Markley JD
    Am J Infect Control; 2019 Oct; 47(10):1263-1264. PubMed ID: 31153713
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sparing carbapenem usage.
    Wilson APR
    J Antimicrob Chemother; 2017 Sep; 72(9):2410-2417. PubMed ID: 28637307
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antimicrobial use metrics and benchmarking to improve stewardship outcomes: methodology, opportunities, and challenges.
    Ibrahim OM; Polk RE
    Infect Dis Clin North Am; 2014 Jun; 28(2):195-214. PubMed ID: 24857388
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Impact of antimicrobial stewardship program on antimicrobial usage and detection rate of multidrug-resistant gram-negative bacteria].
    Xu YL; Hu LM; Xie ZZ; Dong YW; Dong L
    Zhonghua Er Ke Za Zhi; 2019 Jul; 57(7):553-558. PubMed ID: 31269557
    [No Abstract]   [Full Text] [Related]  

  • 9. An Antimicrobial Stewardship Program Based on Systematic Infectious Disease Consultation in a Rehabilitation Facility.
    Tedeschi S; Trapani F; Giannella M; Cristini F; Tumietto F; Bartoletti M; Liverani A; Pignanelli S; Toni L; Pederzini R; Cavina A; Viale P
    Infect Control Hosp Epidemiol; 2017 Jan; 38(1):76-82. PubMed ID: 27745559
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Implementation of a carbapenem prescribing algorithm at a community hospital.
    Shimata SE; Antczak CM; Yu PS; Trivedi KK
    Infect Control Hosp Epidemiol; 2018 Dec; 39(12):1503-1504. PubMed ID: 30326989
    [No Abstract]   [Full Text] [Related]  

  • 11. Assessment of appropriate carbapenem prescribing in stewardship programmes.
    Canouï E; Gauzit R; Bruneau A; Alviset S; Hays C; Charpentier J; Batista R; Kernéis S
    J Hosp Infect; 2018 Nov; 100(3):277-279. PubMed ID: 29614244
    [No Abstract]   [Full Text] [Related]  

  • 12. Impact of daily versus weekly service of infectious diseases consultation on hospital antimicrobial consumption: a retrospective study.
    Cona A; Gazzola L; Viganò O; Bini T; Marchetti GC; d'Arminio Monforte A
    BMC Infect Dis; 2020 Nov; 20(1):812. PubMed ID: 33160320
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inappropriate use of carbapenems in an internal medicine ward: Impact of a carbapenem-focused antimicrobial stewardship program.
    Faraone A; Poggi A; Cappugi C; Tofani L; Riccobono E; Giani T; Fortini A
    Eur J Intern Med; 2020 Aug; 78():50-57. PubMed ID: 32303455
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Benchmarking of antibiotic usage: An adjustment to reflect antibiotic stewardship program outcome in a hospital in Saudi Arabia.
    Momattin H; Al-Ali AY; Mohammed K; Al-Tawfiq JA
    J Infect Public Health; 2018; 11(3):310-313. PubMed ID: 28864362
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of carbapenem restriction on prescribing trends for immunocompromised wards at an academic medical center.
    Kirk A; Pierce J; Doll M; Lee K; Pakyz A; Kim J; Markley D; De la Cruz O; Bearman G; Stevens MP
    Am J Infect Control; 2019 Aug; 47(8):1035-1037. PubMed ID: 30732979
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of a Carbapenem Antimicrobial Stewardship Program on Patient Outcomes.
    Seah VXF; Ong RYL; Lim ASY; Chong CY; Tan NWH; Thoon KC
    Antimicrob Agents Chemother; 2017 Sep; 61(9):. PubMed ID: 28717037
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of a multimodal strategy combining a new standard of care and restriction of carbapenems, fluoroquinolones and cephalosporins on antibiotic consumption and resistance of Pseudomonas aeruginosa in a French intensive care unit.
    Abbara S; Pitsch A; Jochmans S; Hodjat K; Cherrier P; Monchi M; Vinsonneau C; Diamantis S
    Int J Antimicrob Agents; 2019 Apr; 53(4):416-422. PubMed ID: 30537533
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A national quality incentive scheme to reduce antibiotic overuse in hospitals: evaluation of perceptions and impact.
    Islam J; Ashiru-Oredope D; Budd E; Howard P; Walker AS; Hopkins S; Llewelyn MJ
    J Antimicrob Chemother; 2018 Jun; 73(6):1708-1713. PubMed ID: 29506043
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical impact of a prospective audit with intervention and feedback without carbapenem restriction in patients receiving carbapenem injection.
    Fujibayashi A; Niwa T; Takeichi S; Suzuki K; Ohta H; Niwa A; Tsuchiya M; Yamamoto M; Hatakeyama D; Suzuki A; Baba H; Murakami N; Itoh Y
    Int J Clin Pract; 2019 Jan; 73(1):e13262. PubMed ID: 30259617
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Variable impact of an antimicrobial stewardship programme in three intensive care units: time-series analysis of 2012-2017 surveillance data.
    Abbara S; Domenech de Cellès M; Batista R; Mira JP; Poyart C; Poupet H; Casetta A; Kernéis S
    J Hosp Infect; 2020 Feb; 104(2):150-157. PubMed ID: 31605739
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.